One of the suggested genes to be involved in the pathogenesis of this deletion is the BIRC3 gene, a negative regulator of NF-κB, which is monoallelically deleted in ~80% of del(11q) CLL cases. Here, BIRC3 is linked to B-cell chronic lymphocytic leukemia.